26.25
0.00
(0.00%)
At close: January 10 at 3:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in DKK | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | -- | 3 | 3 |
| Avg. Estimate | 1.87B | -- | 5.6B | 6.68B |
| Low Estimate | 1.87B | -- | 5.49B | 6.5B |
| High Estimate | 1.87B | -- | 5.76B | 6.95B |
| Year Ago Sales | 2.45B | -- | 7.06B | 5.6B |
| Sales Growth (year/est) | -23.63% | -- | -20.72% | 19.24% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BVNKF | -- | -- | -- | -- |
| S&P 500 | 8.70% | 11.55% | 14.03% | 13.42% |
Related Tickers
PSH.DU Sernova Corp
0.1496
+4.11%
K5F.BE Genenta Science SPA
4.8200
-1.63%
SG7.MU Sage Therapeutics Inc
5.73
0.00%
41O.F Outlook Therapeutics, Inc.
2.0600
+0.98%
6C1.SG CytomX Therapeutics Inc
0.8410
-9.52%
4A3.F Immatics N.V.
6.84
+1.71%
PSH.SG Sernova Corp
0.1441
-6.97%
PSH.F Sernova Corp.
0.1479
-4.58%
05Y.F Vivoryon Therapeutics N.V.
2.0200
+1.51%
SEOVF Sernova Corp.
0.1500
0.00%